Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$8.04 USD
+0.13 (1.64%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $7.93 -0.11 (-1.37%) 4:34 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Aligos Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ALGS 8.04 +0.13(1.64%)
Will ALGS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALGS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALGS
Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates
Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Lags Revenue Estimates
ALGS: What are Zacks experts saying now?
Zacks Private Portfolio Services
UniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates
Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?
Other News for ALGS
Earnings Scheduled For August 6, 2025
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025 | ALGS ...
Aligos Therapeutics (ALGS) Grants Stock Options to New Employees | ALGS Stock News
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ALGS ...
Aligos Therapeutics announces inducement grants under Nasdaq listing rule